Ceftazidime-avibactam for gram-negative multidrug-resistant bacteria in hematological patients: a single-center experience

Research output: Contribution to journalArticle

Abstract

We have read with interest the paper conducted by the SEIFEM group, concerning the severe problem of multidrug-resistant (MDR) infection in the hematological setting. In a multicentric prospective observational study, Cattaneo and colleagues recorded a colonization rate of 6.5% at admission, with a 16% probability of MDR-related bloodstream infection (BSI), particularly in neutropenic patients. Among them, a carbapenem-resistant gram-negative bacteria was responsible for the 59% of the colonized patients
Original languageEnglish
Pages (from-to)190-191
Number of pages2
JournalTransfusion and Apheresis Science
DOIs
Publication statusPublished - 2019

Keywords

  • We have read with interest the paper conducted by the SEIFEM group, concerning the severe problem of multidrug-resistant (MDR) infection in the hematological setting. In a multicentric prospective observational study, Cattaneo and colleagues recorded a colonization rate of 6.5% at admission, with a 16% probability of MDR-related bloodstream infection (BSI), particularly in neutropenic patients. Among them, a carbapenem-resistant gram-negative bacteria was responsible for the 59% of the colonized patients

Fingerprint

Dive into the research topics of 'Ceftazidime-avibactam for gram-negative multidrug-resistant bacteria in hematological patients: a single-center experience'. Together they form a unique fingerprint.

Cite this